ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steenhuis, L.
Right arrow Articles by van der Mark, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steenhuis, L.
Right arrow Articles by van der Mark, T.
Eur Respir J 2000; 16: 276-281
Copyright © ERS Journals Ltd 2000


Original Articles

Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension

LH Steenhuis, HJ Groen, GH Koeter, and TW van der Mark

The transfer factor of the lung for carbon monoxide (TL,CO) is decreased in patients with pulmonary hypertension. The pulmonary membrane diffusion capacity (Dm) and pulmonary capillary blood volume (Vc), were studied to establish: 1) the relative contribution of the components of the transfer factor to the decrease in TL,CO; 2) whether differences exist between primary pulmonary hypertension (PPH) and chronic thromboembolic pulmonary hypertension (CTEPH); and 3) the relationship between these parameters and haemodynamic parameters. Dm and Vc were determined in 19 patients with PPH and in eight patients with CTEPH. The patients had been referred for consideration for lung transplantation. Haemodynamic parameters were assessed by heart catheterization. In the PPH group, Vc was reduced in 12 of 19 patients (mean+/-SD Vc 72+/-14% of the predicted value) and Dm in 17 of 19 patients (60+/-22% pred). In the CTEPH group, Vc was reduced in six of eight patients and Dm in seven of eight patients. The mean TL,CO Dm and Vc values were similar to those in the PPH group. The reduction in pulmonary membrane diffusion capacity was significantly greater than that in pulmonary capillary blood volume. No differences in pulmonary and cardiovascular functional values were found between the groups. Right atrial pressure showed a significant negative correlation with pulmonary capillary blood volume and an increased pulmonary vascular resistance was associated with a decrease in pulmonary membrane diffusion capacity. These results suggest pronounced functional impairment of the alveolocapillary membrane in these patients.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. G. Corsico, A. M. D'Armini, I. Cerveri, C. Klersy, E. Ansaldo, R. Niniano, E. Gatto, C. Monterosso, M. Morsolini, S. Nicolardi, et al.
Long-term Outcome after Pulmonary Endarterectomy
Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 419 - 424.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. H. Alzeer, A. F. Al-Mobeirek, H. A. K. Al-Otair, U. A. F. Elzamzamy, I. A. Joherjy, and A. S. Shaffi
Right and Left Ventricular Function and Pulmonary Artery Pressure in Patients With Bronchiectasis
Chest, February 1, 2008; 133(2): 468 - 473.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J. Suntharalingam, R. D Machado, L. D Sharples, M. R Toshner, K. K Sheares, R. J Hughes, D. P Jenkins, R. C Trembath, N. W Morrell, and J. Pepke-Zaba
Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension
Thorax, July 1, 2007; 62(7): 617 - 622.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
I. van der Lee, P. Zanen, J. C. Grutters, R. J. Snijder, and J. M.M. van den Bosch
Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension.
Chest, February 1, 2006; 129(2): 378 - 383.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Sofia, M. Maniscalco, P. Carratu, and O. Resta
End points for pulmonary arterial hypertension: a way backward
Eur. Respir. J., November 1, 2004; 24(5): 890 - 891.
[Full Text] [PDF]


Home page
ChestHome page
M. Bonay, C. Bancal, D. de Zuttere, F. Arnoult, G. Saumon, and F. Camus
Normal Pulmonary Capillary Blood Volume in Patients With Chronic Infiltrative Lung Disease and High Pulmonary Artery Pressure
Chest, November 1, 2004; 126(5): 1460 - 1466.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. McGoon, D. Gutterman, V. Steen, R. Barst, D. C. McCrory, T. A. Fortin, and J. E. Loyd
Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines
Chest, July 1, 2004; 126(1_suppl): 14S - 34S.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
X.-G. Sun, J. E. Hansen, R. J. Oudiz, and K. Wasserman
Pulmonary function in primary pulmonary hypertension
J. Am. Coll. Cardiol., March 19, 2003; 41(6): 1028 - 1035.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. F. Fedullo, W. R. Auger, K. M. Kerr, and L. J. Rubin
Chronic Thromboembolic Pulmonary Hypertension
N. Engl. J. Med., November 15, 2001; 345(20): 1465 - 1472.
[Full Text] [PDF]


Home page
Eur Respir JHome page
P. Zanen, I. van der Lee, T. van der Mark, and J.M.M. van den Bosch
Reference values for alveolar membrane diffusion capacity and pulmonary capillary blood volume
Eur. Respir. J., November 1, 2001; 18(5): 764 - 769.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the European Respiratory Society.